{"id":"W2590413398","doi":"10.1200/jco.2013.31.6_suppl.153","title":"Results of a phase II study of sunitinib (SU) maintenance after response to docetaxel in metastatic castration-resistant prostate cancer (mCRPC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; Medicine Hat College; BC Cancer Agency","funders":"","keywords":"Medicine; Tolerability; Docetaxel; Prostate cancer; Clinical endpoint; Internal medicine; Adverse effect; Sunitinib; Oncology; Phases of clinical research; Progression-free survival; Urology; Clinical trial; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002785373,0.001289482,0.002754804,0.0003564993,0.0005356264,0.0007681897,0.0008264541,0.00110086,0.002738038],"category_scores_gemma":[0.001413265,0.0005897974,0.001532745,0.0004184086,0.000725825,0.0006840595,0.0002360935,0.002166053,0.0006641029],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008925463,"about_ca_system_score_gemma":0.001352227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001146144,"about_ca_topic_score_gemma":0.002483264,"domain_scores_codex":[0.9992952,0.0003612908,0.00005651248,0.000107819,0.00005483414,0.0001244312],"domain_scores_gemma":[0.9987352,0.0002525242,0.0002654396,0.000120524,0.00008026088,0.0005460624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7409892,0.07212042,0.0152988,0.00094458,0.002725195,0.0005087333,0.0005157846,0.00193453,0.05528763,0.0001143072,0.004328619,0.1052322],"study_design_scores_gemma":[0.3175325,0.6344444,0.0399302,0.00003132746,0.001106111,0.0004941531,0.00005246011,0.0008097152,0.003712974,0.00007861936,0.001771571,0.00003597271],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994828,0.002046125,0.0003657231,0.000200314,0.00007711937,0.00107021,0.0007189461,0.0000647198,0.0006288405],"genre_scores_gemma":[0.9944479,0.0009951389,0.0007383856,0.0003094187,0.0001175901,0.0007833135,0.001740099,0.00002815029,0.0008399396],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002785373,"threshold_uncertainty_score":0.01473063,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1578829523383898,"score_gpt":0.5247198377054069,"score_spread":0.3668368853670171,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}